Stocks and Investing
Stocks and Investing
Mon, October 3, 2022
[ Mon, Oct 03rd 2022
] - WOPRAI
Sun, October 2, 2022
[ Sun, Oct 02nd 2022
] - WOPRAI
Fri, September 30, 2022
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
[ Fri, Sep 30th 2022
] - WOPRAI
Chris Howerton Maintained (AXSM) at Strong Buy with Decreased Target to $90 on, Sep 30th, 2022
Chris Howerton of Jefferies, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $92 to $90 on, Sep 30th, 2022.
Chris has made no other calls on AXSM in the last 4 months.
There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 0 agree with Chris's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Chris
- Graig Suvannavejh of "Mizuho" Initiated at Strong Buy and Held Target at $76 on, Wednesday, September 7th, 2022
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
- Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022
Contributing Sources